Aranesp 30 mcg - Amgen Precision Formula
Aranesp is a professional-grade pharmaceutical solution designed for targeted hematopoietic support. Formulated by Amgen, this product is engineered for precision and adheres to high-quality manufacturing standards for specialized use.
Specifications
| Active Substance | Erythroponess/Darbepoetin alfa |
| Form | 1 syringe x 0.5 ml x 30 mcg |
| Manufacturer | Amgen |
How it Works
Aranesp utilizes Darbepoetin alfa, a recombinant protein that stimulates the process of erythropoiesis. Unlike standard recombinant human erythropoietin (rhEPO), Darbepoetin alfa features a unique molecular structure containing five N-linked carbohydrate chains. This increased carbohydrate content results in a significantly longer half-life in vivo compared to rhEPO, providing more sustained activity.
Despite its structural differences, Darbepoetin alfa retains a very narrow and high specificity for the erythropoietin receptor. As a growth factor, its primary pharmacological action is focused on the stimulation of red blood cell production through the hematopoietic system.
This advanced formulation is designed for stability and effectiveness, making it a reliable choice for professionals requiring high-specification hematological agents.